Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
308 |
|
Actual shortage: | 11 (4%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 5 (2%) | |
Resolved: | 292 (95%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
48 (16%) |
|
Overdue reports |
4 (36%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2021-10-05 | 2021-11-11 | 146679 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-04-13 | 2022-10-05 | 158798 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-04-13 | 2022-05-01 | 158801 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-04-28 | 2022-05-24 | 159570 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-06-27 | 2022-08-21 | 163521 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-07-29 | 2022-08-21 | 165704 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-10-03 | 2023-02-09 | 170965 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-10-03 | 2022-12-05 | 170968 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-10-03 | 2023-02-09 | 170971 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2023-01-02 | 2023-01-26 | 179693 |
SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2024-03-06 | 2024-05-06 | 221460 |
POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2017-05-10 | 2017-05-27 | 10000 |
POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2021-10-01 | 2021-10-22 | 146596 |
POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2022-04-13 | 2022-11-03 | 158777 |
POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2022-04-13 | 2022-05-02 | 158780 |
POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2022-04-26 | 2023-04-13 | 159355 |
MANNITOL INJECTION, USP | 25% | SOLUTION | Resolved | 2022-06-08 | 2022-10-13 | 162159 |
AMPICILLIN FOR INJECTION, USP | 250MG | POWDER FOR SOLUTION | Resolved | 2024-04-29 | 2024-05-16 | 226471 |
BIVALIRUDIN FOR INJECTION | 250MG | POWDER FOR SOLUTION | Resolved | 2021-11-24 | 2022-02-04 | 149848 |
BIVALIRUDIN FOR INJECTION | 250MG | POWDER FOR SOLUTION | Resolved | 2022-10-02 | 2023-01-02 | 170875 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0